1st Counsel – Lifestyle
Author:
Dermata Therapeutics
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
April 2, 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
March 26, 2026
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
March 10, 2026
Dermata Opens a New Chapter with the Release of Tome Skincare
March 5, 2026